Effects of Aerobic Exercise on Systemic Insulin Degludec Concentrations in People with Type 1 Diabetes

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2021 Sep 30

PMID 34590906

Authors

David Herzig

Michael Groessl

Mario Alvarez-Martinez

Gemma Reverter-Branchat

Christos T Nakas

Christophe Kosinski

Christoph Stettler

Lia Bally

Affiliations

Soon will be listed here.

Abstract

Background: There is conflicting evidence on the effect of exercise on systemic insulin concentrations in adults with type 1 diabetes.

Methods: This prospective single-arm study examined the effect of exercise on systemic insulin degludec (IDeg) concentrations. The study involved 15 male adults with type 1 diabetes (age 30.7 ± 8.0 years, HbA1c 6.9 ± 0.7%) on stable IDeg regimen. Blood samples were collected every 15 minutes at rest, during 60 minutes of cycling (66% VOmax) and until 90 minutes after exercise termination. IDeg concentrations were quantified using high-resolution mass-spectrometry and analyzed applying generalized estimation equations.

Results: Compared to baseline, systemic IDeg increased during exercise over time ( < .001), with the highest concentrations observed toward the end of the 60-minute exercise (17.9% and 17.6% above baseline after 45 minutes and 60 minutes, respectively). IDeg levels remained elevated until the end of the experiment (14% above baseline at 90 minutes after exercise termination, < .001).

Conclusions: A single bout of aerobic exercise increases systemic IDeg exposure in adults on a stable basal IDeg regimen. This finding may have important implications for future hypoglycemia mitigation strategies around physical exercise in IDeg-treated patients.

References

Frank S, Jbaily A, Hinshaw L, Basu R, Basu A, Szeri A . Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes. J Pharmacokinet Pharmacodyn. 2018; 45(6):829-845. PMC: 8237803. DOI: 10.1007/s10928-018-9611-z. View

Pitt J, McCarthy O, Hoeg-Jensen T, Wellman B, Bracken R . Factors Influencing Insulin Absorption Around Exercise in Type 1 Diabetes. Front Endocrinol (Lausanne). 2020; 11:573275. PMC: 7609903. DOI: 10.3389/fendo.2020.573275. View

Heise T, Nosek L, Bottcher S, Hastrup H, Haahr H . Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes. Diabetes Obes Metab. 2012; 14(10):944-50. DOI: 10.1111/j.1463-1326.2012.01638.x. View

Kosinski C, Herzig D, Laesser C, Nakas C, Melmer A, Vogt A . A Single Load of Fructose Attenuates the Risk of Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes on Ultra-Long-Acting Basal Insulin: A Randomized, Open-Label, Crossover Proof-of-Principle Study. Diabetes Care. 2020; 43(9):2010-2016. DOI: 10.2337/dc19-2250. View

Basu R, Johnson M, Kudva Y, Basu A . Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther. 2014; 16(6):331-7. PMC: 4029043. DOI: 10.1089/dia.2014.0097. View

Brugnara L, Vinaixa M, Murillo S, Samino S, Rodriguez M, Beltran A . Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS One. 2012; 7(7):e40600. PMC: 3394718. DOI: 10.1371/journal.pone.0040600. View

McAuley S, Horsburgh J, Ward G, La Gerche A, Gooley J, Jenkins A . Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia. 2016; 59(8):1636-44. DOI: 10.1007/s00125-016-3981-9. View

Jonassen I, Havelund S, Hoeg-Jensen T, Steensgaard D, Wahlund P, Ribel U . Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm Res. 2012; 29(8):2104-14. PMC: 3399081. DOI: 10.1007/s11095-012-0739-z. View

Aronson R, Li A, Brown R, McGaugh S, Riddell M . Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label,.... Lancet Diabetes Endocrinol. 2020; 8(6):511-523. DOI: 10.1016/S2213-8587(20)30114-5. View

10.

Reverter-Branchat G, Groessl M, Nakas C, Prost J, Antwi K, Niederkofler E . Rapid quantification of insulin degludec by immunopurification combined with liquid chromatography high-resolution mass spectrometry. Anal Bioanal Chem. 2020; 412(30):8351-8359. PMC: 7680744. DOI: 10.1007/s00216-020-02971-4. View

11.

Moser O, Eckstein M, Mueller A, Birnbaumer P, Aberer F, Koehler G . Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial. Diabetes Obes Metab. 2018; 21(2):349-356. PMC: 6587463. DOI: 10.1111/dom.13534. View

12.

Reddy R, Resalat N, Wilson L, Castle J, Youssef J, Jacobs P . Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2019; 13(5):919-927. PMC: 6955453. DOI: 10.1177/1932296818823792. View

13.

Haahr H, Heise T . A review of the pharmacological properties of insulin degludec and their clinical relevance. Clin Pharmacokinet. 2014; 53(9):787-800. PMC: 4156782. DOI: 10.1007/s40262-014-0165-y. View

14.

Ferrannini E, Linde B, Faber O . Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. Clin Physiol. 1982; 2(1):59-70. DOI: 10.1111/j.1475-097x.1982.tb00007.x. View